dexamethasone,carfilzomib,daratumumab,lenalidomide
amgen,janssen
['daratumumab', ' lena', 'lenalidomide', 'dexamethasone', 'multiple myeloma', 'carfilzomib']
a litany of genomic determinants of response to combination carfilzomib, lenalidomide, and dexamethasone with #daratumumab among patients with newly diagnosed multiple myeloma have been uncovered in new #ash22 data: 
Breaking news, patient stories & FDA updates within the rare disease community. Listen to our podcast: https://t.co/xUkFDfCDUV, hosted by @GiulianaGrossi